Humain VenturesCo-founder and Managing Partner
Until Present
Early-stage fund investing at the intersection of AI and biology: therapeutics, prevention and human health.
Aneil Mallavarapu is co-founder and Managing Partner of Humain Ventures, an Austin firm that backs founders building the future of therapeutics, prevention and human health. A mathematical biologist and five-time founder, he earned a PhD in biochemistry and cell biology at UCSF. At Harvard Medical School's Department of Systems Biology he created Little b, a language for modeling living systems, work recognized with the Council of Systems Biology Technology Award. He co-founded the AI companies Precise.ly and DeepDialog, is an independent board member of the Sol Foundation, and with Linea Avey co-founded The Lifespan Project. He writes about AI and biology on Substack.
Aneil Mallavarapu is co-founder and Managing Partner of Humain Ventures, an Austin firm that backs founders building the future of therapeutics, prevention and human health. A mathematical biologist and five-time founder, he earned a PhD in biochemistry and cell biology at UCSF. At Harvard Medical School's Department of Systems Biology he created Little b, a language for modeling living systems, work recognized with the Council of Systems Biology Technology Award. He co-founded the AI companies Precise.ly and DeepDialog, is an independent board member of the Sol Foundation, and with Linea Avey co-founded The Lifespan Project. He writes about AI and biology on Substack.
Until Present
Early-stage fund investing at the intersection of AI and biology: therapeutics, prevention and human health.
1999 — 2004